Skip to main content
. 2020 Oct 15;7:191–199. doi: 10.2147/JHC.S274349

Table 1.

Baseline Characteristics of Patients After TACE Treatment at the Second Follow-Up Visit

Characteristics ΔPLT (×109/L) P# value P$ value
>-20, <20 ≤ −20 ≥20
N 178 249 170
Age (yrs, median±SD) 55.8 ± 11.3 51.8 ± 12.5 53.4 ± 12.2 <0.001 0.042
Gender 0.467 0.114
 Male 167 (93.8%) 229 (92.0%) 151 (88.8%)
 Female 11 (6.2%) 20 (8.0%) 19 (11.2%)
PS score 0.666 0.72
 0 148 (83.1%) 203 (81.5%) 139 (81.8%)
 1 30 (16.9%) 46 (18.5%) 31 (18.2%)
Diameter of main tumour (cm) 0.024 0.021
 <5 108 (60.7%) 123 (49.6%) 82 (48.2%)
 ≥5 70 (39.3%) 125 (50.4%) 88 (51.8%)
AFP (ng/mL) 0.03 0.285
 <25 76 (44.4%) 69 (33.5%) 64 (38.8%)
 ≥25 95 (55.6%) 137 (66.5%) 101 (61.2%)
Hgb (g/L) 0.91 0.107
 <120 50 (28.1%) 46 (27.5%) 62 (36.5%)
 ≥120 128 (71.9%) 121 (72.5%) 108 (63.5%)
CRP (mg/L) 0.035 <0.001
 <10 107 (66.0%) 89 (54.6%) 65 (44.5%)
 ≥10 55 (34.0%) 74 (45.4%) 81 (55.5%)
WBC (109/L) 0.239 0.114
 <11 166 (93.8%) 150 (90.4%) 150 (88.8%)
 ≥11 11 (6.2%) 16 (9.6%) 19 (11.2%)
No. of intrahepatic lesions 0.404 0.224
 0 55 (30.9%) 62 (25.0%) 41 (24.1%)
 ≤3 46 (25.8%) 69 (27.8%) 40 (23.5%)
 >3 77 (43.3%) 117 (47.2%) 89 (52.4%)
Location of lesions 0.073 0.03
 None 55 (30.9%) 62 (25.0%) 41 (24.1%)
 Left/Right 56 (31.5%) 65 (26.2%) 42 (24.7%)
 Both 67 (37.6%) 121 (48.8%) 87 (51.2%)
Child-Pugh class <0.001 0.235
 A 87 (48.9.0%) 5 (2.0%) 10 (5.9%)
 B 19 (10.7%) 107 (43.0%) 80 (47.1%)
 NA* 72 (40.4%) 137 (55.0%) 80 (47.1%)

Notes: ΔPLT=the change value of platelet count after TACE. Differences are compared using the chi-square test for categorical measures and Kruskal–Wallis Test for continuous measures. Numbers that do not add up to 597 are attributable to missing data. #ΔPLT≤-20 vs ΔPLT within±20. $ΔPLT≥20 vs ΔPLT within±20. *Include 3 patients with class Child-Pugh C.